OCT 20, 2021 2:30 PM PDT

Structural Characterization of Short Oligonucleotide Therapeutics by Solution NMR

C.E. Credits: P.A.C.E. CE Florida CE
Speaker

Abstract

Short oligonucleotides are an emerging platform for the development of biopharmaceuticals to treat various diseases, including those that are inaccessible to small molecule- and protein-based approaches. Despite the increasing focus on short oligonucleotide therapeutics, standardized methods to rigorously characterize the structure of these molecules, which is essential for drug development and quality control purposes, are not yet fully established. High-resolution NMR spectroscopy is increasingly utilized to characterize the structure of protein-based therapeutics, including monoclonal antibodies, yet this technology has only sparingly been applied to short oligonucleotides. Recent advances in NMR hardware and methodologies allow for the rapid acquisition of NMR spectra under full formulation conditions and at natural isotopic abundance. Furthermore, the non-native chemistries added to enhance the pharmacological stability of short oligonucleotide therapeutics afford additional NMR-active handles of 19F and 31P, which, at 100 % natural isotopic abundance, are more sensitive than 13C (1.1 %) and 15N (0.36 %). Here we demonstrate the applicability of NMR methods to structurally “fingerprint” short oligonucleotide therapeutics to aid the biopharmaceutical industry and regulators during multiple phases of the clinical pipeline, including discovery, manufacturing, and quality control. The demonstration of NMR fingerprinting methods for short oligonucleotide therapeutics allows for the assessment of quality attributes at the atomic level, providing greater confidence in the overall structural integrity of the drug. This benchmarking study provides a pathway for the implementation of NMR fingerprinting as a high resolution structural technique to complement other analytical approaches used during drug development and quality. 

Learning Objectives:

1. Describe how NMR spectra act as structural “fingerprints” of short oligonucleotide therapeutics.

2. Break down how NMR methods can be applied to a variety of structural features, including both native and non-native chemistries. 


Show Resources
You May Also Like
SEP 17, 2021 12:00 PM CST
C.E. CREDITS
SEP 17, 2021 12:00 PM CST
Date: September 16, 2021 Time: 9:00pm (PDT), 12:00am (EDT) 3D cellular models like organoids and spheroids offer an opportunity to better understand complex biology in a physiologically rele...
SEP 14, 2021 7:00 AM PDT
C.E. CREDITS
SEP 14, 2021 7:00 AM PDT
Date: September 14, 2021 Time: 7am PDT, 10am EDT, 4pm CEST A conventional thermal cycler has long been a commodity product in the lab and end-point PCR techniques can be completed almost wit...
NOV 09, 2021 11:00 AM PST
C.E. CREDITS
NOV 09, 2021 11:00 AM PST
Date: November 09, 2021 Time: 11:00am (PDT), 02:00pm (EDT) Clinical translation of human pluripotent stem cells (hPSCs) requires advanced strategies that ensure safe and robust long-term gro...
SEP 09, 2021 8:00 AM PDT
C.E. CREDITS
SEP 09, 2021 8:00 AM PDT
Date: September 09, 2021 Time: 8:00am (PDT), 11:00am (EDT) Human pluripotent stem cells (PSCs) hold great potentials in regenerative therapies. In this webinar, Chao will first present the c...
DEC 08, 2021 7:00 AM PST
DEC 08, 2021 7:00 AM PST
Date: December 08, 2021 Time: 7:00am (PDT), 10:00am (EDT) Successful bioprocessing is complex and depends on many factors. From the selection of the expression host, media composition, the p...
OCT 27, 2021 6:00 AM PDT
C.E. CREDITS
OCT 27, 2021 6:00 AM PDT
Date: October 27, 2021 Time: 6:00 AM PDT, 9:00 AM EDT Etanercept is a recombinant Fc fusion protein therapeutic that has a complex distribution of post-translation modifications (PTM), such...
Loading Comments...
Show Resources
Event Countdown
  • 0 Days
  • 0 Hours
  • 0 Minutes
  • 0 Seconds